April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review outlines the medicinal uses, phytochemistry, and pharmacology of Hibiscus rosa sinensis, noting its wide-ranging effects like anti-inflammatory and antioxidant properties, but also calls for more research on its safety and precise mechanisms given some extracts affect hematological and biochemical markers.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review found that Hibiscus rosa sinensis extracts exhibit diverse medicinal properties, such as anti-inflammatory and antioxidant effects, with minimal toxicity at high doses, though some altered blood markers, indicating a need for further research into their mechanisms and clinical applications.
October 2022 in “International Journal For Multidisciplinary Research” This review summarizes Hibiscus rosa Sinensis's phytochemistry, pharmacology, and medicinal uses, noting various beneficial effects and the need for further research on its phytochemicals and clinical applications.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses the diverse therapeutic properties of Hibiscus rosa sinensis, including anti-inflammatory and anti-cancer effects, and notes that while most extracts showed no toxicity, some altered biological markers, necessitating further research to explore its medicinal potential through clinical trials.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review outlines the therapeutic uses and phytochemical composition of Hibiscus rosa sinensis, highlighting its potential anti-inflammatory, anti-cancer, and other benefits, but it also calls for more research due to observed changes in hematological and biochemical markers in toxicity tests.
